Evidence map›Paper›PMID 35250951›Full record

ArticleFrontiers in microbiology2022

GC-MS Analysis of Potentially Volatile Compounds of

Doaa Hamad, Heba El-Sayed, Wafaa Ahmed, Hana Sonbol, Mohammed Abdel Halim Ramadan

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Fermented cassava peel withVeterinary world · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Phyto-synthesized silver nanoparticles fromFrontiers in plant science · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Wild Mushrooms: A Hidden Treasure of Novel Bioactive Compounds.International journal of analytical chemistry · 2023
    Article
  14. Lead detoxification of edible fungiFrontiers in nutrition · 2023
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Doaa HamadDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Giza, Egypt.
Heba El-SayedDepartment of Botany and Microbiology, Faculty of Science, Helwan University, Helwan, Egypt.
Wafaa AhmedBiochemistry and Molecular Biology Unit, Department of Cancer Biology, National Cancer Institute, Cairo University, Giza, Egypt.
Hana SonbolDepartment of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Mohammed Abdel Halim RamadanDepartment of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One strategy to manage resistant pathogens and develop potential anticancer drugs is the search for new, promising, and cost-effective medicinal benefits in the field of bioactive metabolites derived from mushrooms. In the current study, Egyptian cultivated

Indexed as

antimicrobialantioxidantapoptosiscell cyclecytotoxicityGC-mass spectroscopyimmunomodulatoryPleurotus ostreatus

Identifiers

PMID35250951
PMCPMC8894875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.